Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: Arandomized, double-blind study

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 3, 2007, Pages 345-350

  Seckin, Dilek ^a,c   Gurbuz, O ^a   Akin, O ^b  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MALTEPE UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Ketoconazole; Metronidazole; Seborrheic dermatitis; Treatment

Indexed keywords

KETOCONAZOLE; KETORAL; METRONIDAZOLE; PLACEBO; ROZA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLOW UP; GEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEBORRHEIC DERMATITIS; SKIN BURNING SENSATION; TREATMENT DURATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; DERMATITIS, SEBORRHEIC; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; FEMALE; GELS; HUMANS; KETOCONAZOLE; MALE; METRONIDAZOLE; MIDDLE AGED; OINTMENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846967787     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01927.x     Document Type: Article

References (11)

1. Plewig G, Jansen T. Seborrheic dermatitis. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, eds. Fitzpatrick's Dermatology in General Medicine, 6th edn. McGraw-Hill, New York, 2003: 1198-1204.
2. Gupta AK, Bluhm R. Seborrheic dermatitis. JEADV 2004; 18: 13-26.
3. Stratigos JD, Antoniou C, Katsambas A et al. Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. J Am Acad Dermatol 1988; 19: 850-853.
4. Ortonne JP, Lacour JP, Vietta A, Le Fichoux Y. Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05 % lotion in the treatment of seborrheic dermatitis in adults. Dermatology 1992; 184: 275-280.
5. Parsad D, Pandhi R, Negi KS, Kumar B. Topical metronidazole in seborrheic dermatitis - a double-blind study. Dermatology 2001; 202: 35-37.
6. Koca R, Altinyazar C, Estürk E. Is topical metronidazole effective in seborrheic dermatitis? A double-blind study. Int J Dermatol 2003; 42: 632-635.
7. Miyachi Y, Imamura S, Niwa Y. Anti-oxidant action of metronidazole: A possible mechanism of action in rosacea. Br J Dermatol 1986; 114: 231-234.
8. Aizawa H, Michihito N, Kon Y. Influence of oral metronidazole on the endocrine milieu and sebum excretion rate. J Dermatol 1992; 19: 959-963.
9. Nielsen PG. In vitro antifungal effect of metronidazole on Pityrosporum ovale. Mykosen 1984; 27: 474-476.
10. Cury AE, Miche Hirschfeld MP. Interactions between amphotericin B and nitroimidazoles against Candida albicans. Mycoses 1997; 40: 187-192.
11. Shelanski M, Phillips SB, Potts CE. Evaluation of cutaneous reactivity to recently marketed dermatologic products. Int J Dermatol 1996; 35: 137-140.